AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Episode 51. Venetoclax in AML with Dr. Andrew Wei
Blood Cancer Talks
Exploring MRD Negativity in AML Treatment Decisions
This chapter delves into the recent discoveries surrounding minimal residual disease (MRD) negativity in acute myeloid leukemia (AML) patients, emphasizing findings from the VLA study. It examines the impact of MRD negativity on treatment outcomes and discusses its implications for therapy management and patient care strategies.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode